Real-world evidence of patients who received psilocybin through Canada’s Special Access Program

Read full text Summarise with VIRAT
Authors: Jennifer Docherty
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Secondary analysis of real-world data from Canada's Special Access Program requests for psilocybin from program inception January 2022 to mid March 2026

Fields of Study & Subjects

Psychedelics and Drug Studies Opioid Use Disorder Treatment Cannabis and Cannabinoid Research

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint